rs137874941

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001323289.2(CDKL5):​c.99+34A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,035,356 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 45 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00063 ( 0 hom., 16 hem., cov: 23)
Exomes 𝑓: 0.00012 ( 0 hom. 29 hem. )

Consequence

CDKL5
NM_001323289.2 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.90

Publications

0 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
  • CDKL5 disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • precocious puberty
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-18510888-A-G is Benign according to our data. Variant chrX-18510888-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 189542.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000635 (71/111831) while in subpopulation AFR AF = 0.00217 (67/30858). AF 95% confidence interval is 0.00175. There are 0 homozygotes in GnomAd4. There are 16 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 71 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKL5NM_001323289.2 linkc.99+34A>G intron_variant Intron 3 of 17 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkc.99+34A>G intron_variant Intron 4 of 21 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.99+34A>G intron_variant Intron 3 of 20 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkc.99+34A>G intron_variant Intron 3 of 17 1 NM_001323289.2 ENSP00000485244.1 O76039-2

Frequencies

GnomAD3 genomes
AF:
0.000635
AC:
71
AN:
111780
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00417
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000223
AC:
40
AN:
179288
AF XY:
0.0000921
show subpopulations
Gnomad AFR exome
AF:
0.00240
Gnomad AMR exome
AF:
0.000184
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000495
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000121
AC:
112
AN:
923525
Hom.:
0
Cov.:
17
AF XY:
0.000113
AC XY:
29
AN XY:
256623
show subpopulations
African (AFR)
AF:
0.00224
AC:
52
AN:
23193
American (AMR)
AF:
0.000172
AC:
6
AN:
34932
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18204
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29314
South Asian (SAS)
AF:
0.00
AC:
0
AN:
50294
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3344
European-Non Finnish (NFE)
AF:
0.0000714
AC:
49
AN:
686453
Other (OTH)
AF:
0.000124
AC:
5
AN:
40167
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000635
AC:
71
AN:
111831
Hom.:
0
Cov.:
23
AF XY:
0.000470
AC XY:
16
AN XY:
34007
show subpopulations
African (AFR)
AF:
0.00217
AC:
67
AN:
30858
American (AMR)
AF:
0.00
AC:
0
AN:
10477
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3563
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5986
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.0000564
AC:
3
AN:
53201
Other (OTH)
AF:
0.00
AC:
0
AN:
1525
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000476
Hom.:
1
Bravo
AF:
0.000695

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 09, 2014
RettBASE
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

- -

CDKL5 disorder Benign:1
Jul 11, 2024
Centre for Population Genomics, CPG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: met The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 3.0 (BA1). -

not provided Benign:1
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDKL5: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.043
DANN
Benign
0.65
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137874941; hg19: chrX-18529008; API